Edwards Peripheral Artery Growth-Factor Data Pooled By NIH’s Lederman
This article was originally published in The Gray Sheet
Executive Summary
Early clinical data profiling Edwards/Sangamo's EW-A-401 gene therapy for intermittent claudication (leg pain) in patients at the National Institutes of Health are expected to appear in the Oct. 19 issue of Circulation